» Articles » PMID: 37430370

Basilar Artery Diameter As Neuroimaging Biomarker in Chinese Fabry Disease Patients

Overview
Publisher Biomed Central
Specialty General Medicine
Date 2023 Jul 10
PMID 37430370
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Fabry disease (FD) is an X-linked lysosomal storage disease resulting from mutations of α-galactosidase A gene, and has been emphasized as one of the etiologies of young stroke and leukoencephalopathy. Vertebrobasilar dolichoectasia (VBD) is a highlighted finding in FD. We aim to examine the utility of VBD in Chinese FD by comparing the differences in basilar artery (BA) diameter of Chinese FD patients against age-matched controls with and without stroke.

Methods: This was a matched case-control study involving 37 Chinese FD patients. The BA diameters were evaluated on axial T2-weighted magnetic resonance imaging and compared to two age-and-gender matched control groups, one with stroke and one without. The association between BA diameter and stroke occurrences and white matter hyperintensities (WMH) were analyzed among all FD patients.

Results: Patients with FD had significantly increased BA diameter compared to controls with and without stroke (p < 0.001). A BA diameter of 4.16 mm could distinguish FD from controls in the stroke subgroup (ROC AUC 0.870, p = 0.001, sensitivity 80% specificity 100%), and with a cut-off of 3.21 mm in the non-stroke subgroup (ROC AUC 0.846, p < 0.001, sensitivity 77.8% specificity 88.9%). Larger BA diameter had more stroke occurrences and was moderately associated with heavier WMH load in terms of higher total FAZEKAS scores. (Spearman's rho = 0.423, p = 0.011).

Conclusion: VBD was also present in Chinese FD patients. BA diameter has high diagnostic utility in identifying FD from a mixed cohort of stroke and normal controls, and carried predictive value in evaluating neurological complications of FD.

Citing Articles

Clinical and Pathophysiologic Correlates of Basilar Artery Measurements in Fabry Disease.

Scaravilli A, Capasso S, Ugga L, Capuano I, Di Risi T, Pontillo G AJNR Am J Neuroradiol. 2024; 45(11):1670-1677.

PMID: 38997124 PMC: 11543084. DOI: 10.3174/ajnr.A8403.


Expanding the Neurological Phenotype of Anderson-Fabry Disease: Proof of Concept for an Extrapyramidal Neurodegenerative Pattern and Comparison with Monogenic Vascular Parkinsonism.

Zedde M, Romani I, Scaravilli A, Cocozza S, Trojano L, Ragno M Cells. 2024; 13(13.

PMID: 38994983 PMC: 11240674. DOI: 10.3390/cells13131131.

References
1.
Pico F, Labreuche J, Amarenco P . Pathophysiology, presentation, prognosis, and management of intracranial arterial dolichoectasia. Lancet Neurol. 2015; 14(8):833-845. DOI: 10.1016/S1474-4422(15)00089-7. View

2.
Fellgiebel A, Muller M, Ginsberg L . CNS manifestations of Fabry's disease. Lancet Neurol. 2006; 5(9):791-5. DOI: 10.1016/S1474-4422(06)70548-8. View

3.
Tanaka M, Sakaguchi M, Miwa K, Okazaki S, Furukado S, Yagita Y . Basilar artery diameter is an independent predictor of incident cardiovascular events. Arterioscler Thromb Vasc Biol. 2013; 33(9):2240-4. DOI: 10.1161/ATVBAHA.113.301467. View

4.
Lin H, Chong K, Hsu J, Yu H, Shih C, Huang C . High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population. Circ Cardiovasc Genet. 2009; 2(5):450-6. DOI: 10.1161/CIRCGENETICS.109.862920. View

5.
Fellgiebel A, Keller I, Martus P, Ropele S, Yakushev I, Bottcher T . Basilar artery diameter is a potential screening tool for Fabry disease in young stroke patients. Cerebrovasc Dis. 2011; 31(3):294-9. DOI: 10.1159/000322558. View